포르모테롤 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "포르모테롤" in Korean language version.

refsWebsite

Global rank Korean rank

4^th place

4^th place

68^th place

145^th place

2^nd place

3^rd place

low place

low place

1books.google.com

3^rd place

9^th place

1web.archive.org

1^st place

1^st place

447^th place

433^rd place

books.google.com

Fischer J, Ganellin CR (2006). 《Analogue-based Drug Discovery》 (영어). John Wiley & Sons. 543쪽. ISBN 9783527607495.

doi.org

dx.doi.org

Anderson GP (1993). “Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.”. 《Life Sci》 52 (26): 2145–60. doi:10.1016/0024-3205(93)90729-m. PMID 8099696.

europa.eu

ema.europa.eu

“List of nationally authorised medicinal products” (PDF). 《ema.europa.eu》. 2023년 6월 17일에 확인함.

fda.gov

“Competitive Generic Therapy Approvals”. 《U.S. Food and Drug Administration (FDA)》. 2023년 6월 29일. 2023년 6월 29일에 원본 문서에서 보존된 문서. 2023년 6월 29일에 확인함.

ginasthma.org

Global Initiative for Asthma (2022). Global Strategy for Asthma Prevention and Management (Updated 2022) (PDF) (보고서).

nih.gov

pubmed.ncbi.nlm.nih.gov

Anderson GP (1993). “Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.”. 《Life Sci》 52 (26): 2145–60. doi:10.1016/0024-3205(93)90729-m. PMID 8099696.

ncbi.nlm.nih.gov

Anderson GP (1993). “Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.”. 《Life Sci》 52 (26): 2145–60. doi:10.1016/0024-3205(93)90729-m. PMID 8099696.

web.archive.org

“Competitive Generic Therapy Approvals”. 《U.S. Food and Drug Administration (FDA)》. 2023년 6월 29일. 2023년 6월 29일에 원본 문서에서 보존된 문서. 2023년 6월 29일에 확인함.